Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Autism spectrum disorder due to AUTS2 deficiency is a rare genetic syndromic intellectual disability characterized by global developmental delay and borderline to severe intellectual disability, autism spectrum disorder with obsessive behavior, stereotypies, hyperactivity but frequently friendly and affable personality, feeding difficulties, short stature, muscular hypotonia, microcephaly, characteristic dysmorphic features (hypertelorism, high arched eyebrows, ptosis, deep and/or broad nasal bridge, broad/prominent nasal tip, short and/or upturned philtrum, narrow mouth, and micrognathia), and skeletal anomalies (kyphosis and/or scoliosis, arthrogryposis, slender habitus and extremities). Other clinical features may include hernias, congenital heart defects, cryptorchidism and seizures.
Data assembled from 7 of 12 sources · Last updated Sep 19, 2026, 11:58 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Features include always present findings: Deep philtrum, Delayed fine motor development, Thick vermilion border, and Wide mouth and others; and very common findings: Intellectual disability, Delayed speech and language development, and Abnormal facial shape. 67 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 14 | Delayed fine motor development, Intellectual disability, Delayed speech and language development |
Muscles | 5 | Generalized hypotonia, Joint stiffness present at birth (arthrogryposis multiplex congenita), Congenital contracture |
Bones and joints | 4 | Sideways curvature of the spine (scoliosis), Excessive outward curvature of the upper spine (kyphosis), Joint contracture of the 5th finger |
Arms and legs | 4 | Clinodactyly of the 5th finger, Abnormal foot morphology, Joint contracture of the 5th finger |
Eyes | 3 | Strabismus, Ptosis, Bilateral ptosis |
Growth and development | 2 | Short stature, Intrauterine growth retardation |
Head and neck | 2 | Microcephaly, Abnormal facial shape |
Digestive system | 2 | Feeding difficulties, Feeding difficulties in infancy |
Skin | 2 | Eczematoid dermatitis, Periauricular skin pits |
Heart and blood vessels | 2 | Abnormal heart morphology, Atrial septal defect |
Pregnancy and birth | 1 | Congenital contracture |
AUTS2 encodes activator of transcription and developmental regulator AUTS2 (1,259 aa). Component of a Polycomb group (PcG) multiprotein PRC1-like complex, a complex class required to maintain the transcriptionally repressive state of many genes, including Hox genes, throughout development. Highest expression in Nerve Tibial (29.9 TPM) and Skin Sun Exposed Lower leg (24.0 TPM).
Autism spectrum disorder due to AUTS2 deficiency is associated with mutations in the AUTS2 gene on chromosome 7.
AUTS2 is classified as a druggable target with score 0.0.
Genetic testing for AUTS2 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for autism spectrum disorder due to AUTS2 deficiency has been reported in the published literature.
Phenotype severity distribution: 6 always present features, 3 very common features, 30 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
1 clinical trial registered, 1 recruiting. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
23 publications have been identified in PubMed for autism spectrum disorder due to AUTS2 deficiency. Research spans Case Report / Case Series (43%), Epidemiology / Natural History (17%), and Review / Meta-Analysis (13%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 10 | 43% |
Disease patterns and progression | 4 | 17% |
Research summaries | 3 | 13% |
Laboratory research | 3 | 13% |
Other research | 1 | 4% |
Testing and diagnosis research | 1 | 4% |
Clinical study results | 1 | 4% |
Zhang Y (2026). [PMID: 41668056](https://pubmed.ncbi.nlm.nih.gov/41668056/). *BMC oral health*. [Epidemiology / Natural History]
Zhu Z (2026). [PMID: 41808101](https://pubmed.ncbi.nlm.nih.gov/41808101/). *BMC Pediatr*. [Case Report / Case Series]
Laaraje A (2026). [PMID: 41809613](https://pubmed.ncbi.nlm.nih.gov/41809613/). *Sultan Qaboos University medical journal*. [Case Report / Case Series]
Liang H (2026). [PMID: 41965552](https://pubmed.ncbi.nlm.nih.gov/41965552/). *BMC Endocr Disord*. [Case Report / Case Series]
Katz K (2026). [PMID: 41518091](https://pubmed.ncbi.nlm.nih.gov/41518091/). *American journal of medical genetics. Part A*. [Case Report / Case Series]
Kostopoulou E (2026). [PMID: 42065018](https://pubmed.ncbi.nlm.nih.gov/42065018/). *Case Rep Neurol Med*. [Case Report / Case Series]
Hossain WA (2025). [PMID: 39941075](https://pubmed.ncbi.nlm.nih.gov/39941075/). *International journal of molecular sciences*. [Review / Meta-Analysis]
Gaudioso F (2025). [PMID: 41562894](https://pubmed.ncbi.nlm.nih.gov/41562894/). *Medical sciences (Basel, Switzerland)*. [Review / Meta-Analysis]
Vinci M (2025). [PMID: 40650163](https://pubmed.ncbi.nlm.nih.gov/40650163/). *International journal of molecular sciences*. [Review / Meta-Analysis]
Shimaoka K (2025). [PMID: 39815005](https://pubmed.ncbi.nlm.nih.gov/39815005/). *The EMBO journal*. [Basic Science / Preclinical]
AI-curated news mentioning autism spectrum disorder due to AUTS2 deficiency
Updated Feb 6, 2026
The National Institutes of Health has submitted a request for review to the Office of Management and Budget regarding the information collection for Autism Spectrum Disorder research. This is part of compliance with the Paperwork Reduction Act.